4 hours Pharma Stock Roundup: JNJ’s 3rd Talc-Related Bankruptcy Filing & More Zacks
JNJ files for voluntary bankruptcy for the third time. Pfizer withdraws sickle-cell drug drug Oxbryta from worldwide markets.
Johnson & Johnson (JNJ) · Pfizer (PFE)